← Back to Search

Media Literacy + Text Messaging Support + Financial Incentives for Smoking Cessation

N/A
Recruiting
Led By Tzeyu Michaud, PhD
Research Sponsored by University of Nebraska
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months
Awards & highlights

Study Summary

This trial tests if a program of media literacy, real-time text messages & incentives can help people quit vaping, with the aim of reducing rates of abstinence.

Who is the study for?
This trial is for young adults aged 19-29 who have been vaping regularly for at least 6 months, want to quit, and have asthma. They must be able to access internet or text messaging services but can't use other nicotine products or already be in a quitting program.Check my eligibility
What is being tested?
The study tests if combining media literacy education with real-time texting support and financial rewards helps people stop vaping better than just one of these methods alone. Participants will either get the combined approach or just one part of it.See study design
What are the potential side effects?
Since this trial involves educational and support interventions rather than medications, traditional side effects are not expected. However, participants may experience stress or frustration related to quitting efforts.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Biochemically verified vaping abstinence
Secondary outcome measures
Biomarkers of toxic exposures
Engagement
Media literacy
+2 more

Trial Design

4Treatment groups
Experimental Treatment
Active Control
Group I: CombinedExperimental Treatment3 Interventions
Participants will receive media literacy e-learning lessons, financial incentive, and an evidence-based text-messaging support program.
Group II: Active controlExperimental Treatment1 Intervention
Participants in this arm will receive an evidence-based text-messaging support.
Group III: Media literacyActive Control2 Interventions
Participants will receive media literacy e-learning lessons and an evidence-based text-messaging support.
Group IV: Financial incentiveActive Control2 Interventions
Participants will receive financial incentive intervention and an evidence-based text-messaging support.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Financial incentive
2016
Completed Phase 3
~61520

Find a Location

Who is running the clinical trial?

University of NebraskaLead Sponsor
539 Previous Clinical Trials
1,144,654 Total Patients Enrolled
National Institute of General Medical Sciences (NIGMS)NIH
269 Previous Clinical Trials
248,730 Total Patients Enrolled
Tzeyu Michaud, PhDPrincipal InvestigatorUniversity of Nebraska
1 Previous Clinical Trials
119 Total Patients Enrolled

Media Library

Vaping cessation program Clinical Trial Eligibility Overview. Trial Name: NCT05586308 — N/A
E-Cigarette Use Research Study Groups: Active control, Media literacy, Combined, Financial incentive
E-Cigarette Use Clinical Trial 2023: Vaping cessation program Highlights & Side Effects. Trial Name: NCT05586308 — N/A
Vaping cessation program 2023 Treatment Timeline for Medical Study. Trial Name: NCT05586308 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any openings for me to take part in this clinical investigation?

"This research endeavor is seeking 80 individuals aged 19-29 who have been clinically diagnosed with asthma (J45) and also report regular vaping over the last 30 days. Additionally, participants must possess access to modern technologies such as cellular data, video chat services, or SMS texting; in addition to an expressed willingness to quit their current smoking habits."

Answered by AI

Is enrollment still ongoing for this research endeavor?

"Based on the information hosted by clinicaltrials.gov, this medical trial is no longer accepting patients. It was initially published on January 1st 2023 and its last update took place October 14th 2022. Although no further recruitment is taking place for this specific study, there are 197 other active trials looking for participants right now."

Answered by AI

Does this investigation accept elderly individuals who are over 75 years of age?

"This trial's admissions policy is limited to persons aged 19-29. There are separate studies for minors and patients over 65, respectively with 22 trials available for the former and 173 for the latter."

Answered by AI

Who else is applying?

What site did they apply to?
Unversity of Nebraska Medical Center
What portion of applicants met pre-screening criteria?
Met criteria
~11 spots leftby Jun 2024